Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Revenues:
Grant	$ 429	$ 238
Sales and services	559	739
Total revenues	988	977
Operating costs and expenses:
Costs of revenues	359	509
Research and development	7,777	7,840
Acquired in-process research and development	13,000	0
General and administrative	4,495	2,219
Intangible amortization	111	586
Total costs and operating expenses	25,742	11,154
Loss from operations	(24,754)	(10,177)
Gain on expiration of derivative liability	5,520	0
Loss on equity investments	(499)	0
Interest expense	(307)	(439)
Interest income	13	0
Income (loss) before income tax expense	(20,027)	(10,616)
Income tax expense (benefit)	0	(178)
Net loss	(20,027)	(10,438)
Net loss attributable to noncontrolling interests	(1,637)	0
Net loss attributable to Sorrento	$ (18,390)	$ (10,438)
Net loss per share - basic and diluted per share attributable to Sorrento	$ (0.48)	$ (0.29)
Weighted-average shares used during period - basic and diluted per share attributable to Sorrento	37,965	36,206